Overview

Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer

Status:
Terminated
Trial end date:
2007-07-01
Target enrollment:
Participant gender:
Summary
This study is to evaluate the efficacy and safety of combination chemotherapy with irinotecan and capecitabine in previously untreated metastatic colorectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
National Cancer Center, Korea
Treatments:
Camptothecin
Capecitabine
Irinotecan